Popular Keywords
Breast cancer
Cancer
Cancer biology
Cancer diagnosis and molecular pathology
Cancer prevention
Cancer survivors
Editorial-Board
- Jinpao Hou
BioMed Technology Holdings Limited,CHINA - Matthias Nees
Medical University of Lublin, Polen - Enas Alkhader
Middle East University,Jordan - Jen-Chung Ko
National Taiwan University Hospital,Taiwan - Rachid Masrour
Sidi Mohamed Ben Abdellah University,Morocco - Karam Soliman
Florida A&M University,USA - Riccardo Memeo
Miulli Hospital,Italia - Michiel Wilhelmus Maria van den Brekel
University of Amsterdam,Netherlands - Dr. Mrozek-Wilczkiewicz Anna
University of Silesia in Katowice,Poland - Dr. Abalde-Cela Sara
International Iberian Nanotechnology Laboratory, INL,Portugal - Dr. Tafuto Salvatore
ENETs Center of Excellence,Italy - Francesco Perri
INT IRCCS Foundation G Pascale, Naples,Italy - Karam F. A. Soliman
Florida A&M University, USA - Yan-Shen Shan
College of Medicine, NCKU,Taiwan - Majdi Imterat
Hadassah University, Israel - Shangwei Zhong
Hengyang Medical School, University of South China,China - Sabina Di Matteo
Unicamillus/Tor Vergata Hospital, Italy - natale calomino
università degli studi di siena, Italy - Chuzhong Li
Beijing Tiantan Hospital, China
Journal Info
- Journal Name: The European Journal of Cancer
- Impact Factor: 2.0
- ISSN: 3064-6731
- DOI: 10.52338/tejoc
- Short Name: TEJOC
- Acceptance rate: 55%
- Volume: 7 (2024)
- Submission to acceptance: 25 days
- Acceptance to publication: 10 days
OUR PUBLICATION BENEFITS
- International Reach
- Peer Review
- Rapid Publication
- Open Access
- High Visibility